Shares of Co-Diagnostics, Inc. (CODX) are up more than 5% in the morning trade on Monday at $6.29.
The molecular diagnostics company today said it has shipped testing reagents for monkeypox virus to one of its international distributors.
As of July 7, 2022, over 6,000 cases of monkeypox have been reported to WHO from 59 countries, the company said.
CODX has traded in the range of $3.66-$11.82 in the past 52 weeks.
Source: Read Full Article
Lates News:
-
Digital Brands Up 9%, Concludes Sundry Acquisition
-
With Bitcoin Above $31,000 Milestone, MicroStrategy’s BTC Stash Is Back In The Green
-
New York AG Pushes To Prohibit Crypto Investments With Retirement Funds
-
Volcon Soars As Co. Gets $100 Mln Pre-orders For Its Fully Electric UTV
-
Bitcoin (BTC/USD) Price Analysis – 6 July 2023